From breast cancer and blood clots to depression and debilitating autoimmune disease, the health of millions of women has been sacrificed to chronic and deadly diseases In the Name of The Pill. This book highlights many of those ailments and examines the role hormonal birth control plays in each. Chapters devoted to individual diseases and conditions include lupus, Multiple Sclerosis, Crohn's disease, infertility, migraines, blood clots, diabetes, hair loss, thyroid and gallbladder disease. Yet, with significantly increased risk for all these conditions, the drug industry still tells us the benefits outweigh the risks. To understand the disconnect, In the Name of The Pill explores the history, economics, and politics that gave us birth control before it was proven safe, and exposes the powerful forces working to keep us in the dark.

Revised for its tenth edition, "The Pill Book" remains the bestselling and and most trusted consumer reference to the most-prescribed drugs in the United States. 32-page color insert. Copyright © Libri GmbH. All rights reserved.

A Chicago Tribune "Best Books of 2014" • A Slate "Best Books 2014: Staff Picks" • A St. Louis Post-Dispatch "Best Books of 2014" The fascinating story of one of the most important scientific discoveries of the twentieth century. We know it simply as "the pill," yet its genesis was anything but simple. Jonathan Eig's masterful narrative revolves around four principal characters: the fiery feminist Margaret Sanger, who was a champion of birth control in her campaign for the rights of women but neglected her own children in pursuit of free love; the beautiful Katharine McCormick, who owed her fortune to her wealthy husband, the son of the founder of International Harvester and a schizophrenic; the visionary scientist Gregory Pincus, who was dismissed by Harvard in the 1930s as a result of his experimentation with in vitro fertilization but who, after he was approached by Sanger and McCormick, grew obsessed with the idea of inventing a drug that could stop ovulation; and the telegenic John Rock, a Catholic doctor from Boston who battled his own church to become an enormously effective advocate in the effort to win public approval for the drug that would be marketed by Searle as Enovid. Spanning the years from Sanger’s heady Greenwich Village days in the early twentieth century to trial tests in Puerto Rico in the 1950s to the cusp of the sexual revolution in the 1960s, this is a grand story of radical feminist politics, scientific ingenuity, establishment opposition, and, ultimately, a sea change in social attitudes. Brilliantly researched and briskly written, The Birth of the Pill is gripping social, cultural, and scientific history.

"The average woman concerned about pregnancy spends approximately thirty years trying to prevent conception. She largely does so alone using prescription birth control, a phenomenon often taken for granted as natural and beneficial in the United States. In Just Get on the Pill, Littlejohn draws on interviews to show how young women come to take responsibility for prescription birth control as the "woman's method" and relinquish control of external condoms as the "man's method." She uncovers how gendered compulsory birth control-in which women are held accountable for preventing and resolving pregnancies in gender-constrained ways-encroaches on women's reproductive autonomy and erodes their ability to protect themselves from disease. In tracing the gendered politics of pregnancy prevention, Littlejohn argues that the gender division of labor in birth control is not natural. It is unjust"--

This document is one of two evidence-based cornerstones of the World Health Organization's (WHO) new initiative to develop and implement evidence-based guidelines for family planning. The first cornerstone, the Medical eligibility criteria for contraceptive use (third edition) published in 2004, provides guidance for who can use contraceptive methods safely. This document, the Selected practice recommendations for contraceptive use (second edition), provides guidance for how to use contraceptive methods safely and effectively once they are deemed to be medically appropriate. The recommendations contained in this document are the product of a process that culminated in an expert Working Group meeting held at the World Health Organization, Geneva, 13-16 April 2004.

IF YOU TAKE NUTRITIONAL SUPPLEMENTS, HERBS, VITAMINS, AND OTHER NATURAL PRODUCTS, YOU NEED THIS BOOK! Compiled by one of America’s leading authorities on natural medicine, The Pill Book Guide to Natural Medicines answers vital questions about the effectiveness and safety of more than 250 of today’s most popular natural remedies. Dr. Murray's unique A-to-F rating system tells you at a glance whether the product has been scientifically proven to work and if there are risks in taking it. Written in clear, accessible language, here is important information on: • What the product is for, and how it works • Safety and effectiveness rating • Possible side effects • Drug and food interactions • Usual dosage • Cautions and warnings • Special concerns for seniors, children, and pregnant women Up-to-date and authoritative, The Pill Book Guide to Natural Medicines also contains Dr. Murray's recommendations for the prevention and treatment of over 70 common conditions, from acne and atherosclerosis to ulcers and varicose veins. Remember, just because a product is “natural” does not mean it is safe. This important reference can help you make wise choices–or even save your health.

Medical Eligibility Criteria for Contraceptive Use reviews the medical eligibility criteria for use of contraception, offering guidance on the safety and use of different methods for women and men with specific characteristics or known medical conditions. The recommendations are based on systematic reviews of available clinical and epidemiological research. It is a companion guideline to Selected Practice Recommendations for Contraceptive Use. Together, these documents are intended to be used by policy-makers, program managers, and the scientific community to support national programs in the preparation of service delivery guidelines. The fourth edition of this useful resource supersedes previous editions, and has been fully updated and expanded. It includes over 86 new recommendations and 165 updates to recommendations in the previous edition. Guidance for populations with special needs is now provided, and a new annex details evidence on drug interactions from concomitant use of antiretroviral therapies and hormonal contraceptives. To assist users familiar with the third edition, new and updated recommendations are highlighted. Everyone involved in providing family planning services and contraception should have the fourth edition of Medical Eligibility Criteria for Contraceptive Use at hand.

Millions of healthy women take a powerful medication every day from their mid-teens to menopause - the Pill - but few know how this drug works or the potential side effects. Contrary to cultural myth, the birth-control pill impacts on every organ and function of the body, and yet most women do not even think of it as a drug. Depression, anxiety, paranoia, rage, panic attacks - just a few of the effects of the Pill on half of the over 80% of women who pop these tablets during their lifetimes. When the Pill was released, it was thought that women would not submit to taking a medication each day when they were not sick. Now the Pill is making women sick. However, there are a growing number of women looking for non-hormonal alternatives for preventing pregnancy. In a bid to spark the backlash against hormonal contraceptives, this book asks: Why can't we criticize the Pill? ,

Women are major consumers and highly proactive when it comes to attending to their health care. In the tradition of the mega-bestseller, THE PILL BOOK, comes a medication guide just for women—a book that addresses their needs, concerns, and questions about the plethora of prescription and over-the-counter drugs available. A mix of narrative and reference, THE WOMEN'S PILL BOOK is speaks directly to the specific health challenges women face: Unique Reproductive Chronic Pain Autoimmune Disorder Heart Disease Hormonal Challenges Prescription Drug Abuse Plus profiles of hundreds of prescription and over-the-counter drugs, including generic and brand name, benefits, side effects, and alternative treatment options.

Evaluates evidence for an increased risk of cancer in women using combined oral contraceptives, progestogen-only hormonal contraceptives, post-menopausal estrogen therapy, and post-menopausal estrogen-progestogen therapy. Although the carcinogenicity of these preparations has been extensively investigated, the book stresses the many complex methodological issues that must be considered when interpreting findings and weighing results. Evidence of an association between use of these preparations and positive effects on health, including a reduced risk of some cancers, is also critically assessed. The first and most extensive monograph evaluates evidence of an association between the use of combined oral contraceptives and cancer at nine sites. Concerning breast cancer, the evaluation concludes that, even if the association is causal, the excess risk for breast cancer associated with patterns of use that are typical today is very small. Studies of predominantly high-dose preparations found an increased risk of hepatocellular carcinoma in the absence of hepatitis viruses. Citing these findings, the evaluation concludes that there is sufficient evidence in humans for the carcinogenicity of combined oral contraceptives. The evaluation also found sufficient evidence for the carcinogenicity of some, but not all, combined preparations in animals. Combined oral contraceptives were classified as carcinogenic to humans. The evaluation also cites conclusive evidence that these agents have a protective effect against cancers of the ovary and endometrium. Progestogen-only contraceptives are evaluated in the second monograph, which considers the association with cancer at six sites. The evaluation found no evidence of an increased risk for breast cancer. Although the evaluation found sufficient evidence in animals for the carcinogenicity of medroxyprogesterone acetate, evidence for the carcinogenicity of progestogen-only contraceptives in humans was judged inadequate. Progestogen-only contraceptives were classified as possibly carcinogenic to humans. The third monograph, on post-menopausal estrogen therapy, considers evidence of an association with cancer at eight sites. Findings from a large number of epidemiological studies indicate a small increase in the risk of breast cancer in women who have used these preparations for five years or more. Studies consistently show an association between use of post-menopausal estrogen therapy and an increased risk for endometrial cancer. Data on the association with other cancers were either inconclusive or suggested no effect on risk. The evaluation concludes that post-menopausal estrogen therapy is carcinogenic to humans. The final monograph evaluates the association between the use of post-menopausal estrogen-progestogen therapy and cancer at four sites. The evaluation of limited data on breast cancer found an increased relative risk observed with long-term use. Data were judged insufficient to assess the effects of past use and of different progestogen compounds, doses, and treatment schedules. For endometrial cancer, the evaluation found an increase in risk relative to non-users when the progestogen was added to the cycle for 10 days or fewer. Post-menopausal estrogen-progestogen therapy was classified as possibly carcinogenic to humans. Concerning post-menopausal therapy in general, the book notes that evidence of carcinogenic risks must be placed in perspective of potential benefits. The prevention of osteoporotic fractures is cited as the best-established benefit. Evidence also suggests that estrogen prevents heart disease and may prevent memory loss and dementia.